5,5',14-tribromo-N'-ethoxycarbonyltetrandrine | 1400914-00-2

• 分子结构分类: 有机化合物 - 木脂素、新木脂素和相关化合物
• 英文名称: 5,5',14-tribromo-N'-ethoxycarbonyltetrandrine
• 英文别名: ethyl (1S,14S)-11,19,26-tribromo-9,20,21,25-tetramethoxy-15-methyl-7,23-dioxa-15,30-diazaheptacyclo[22.6.2.23,6.18,12.114,18.027,31.022,33]hexatriaconta-3(36),4,6(35),8,10,12(34),18(33),19,21,24,26,31-dodecaene-30-carboxylate
• CAS: 1400914-00-2
• 化学式: C₄₀H₄₁Br₃N₂O₈
• 分子量: 917.486
• InChiKey: IVQHCJIVJPWNBS-VMPREFPWSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  9
• 重原子数：
  53
• 可旋转键数：
  6
• 环数：
  8.0
• sp3杂化的碳原子比例：
  0.38
• 拓扑面积：
  88.2
• 氢给体数：
  0
• 氢受体数：
  9

反应信息

• 作为产物：
  描述：

  汉防己甲素 在 N-溴代丁二酰亚胺(NBS) 、 sodium carbonate 作用下， 以 二氯甲烷 、 溶剂黄146 、 三氟乙酸 为溶剂， 反应 7.0h， 生成 5,5',14-tribromo-N'-ethoxycarbonyltetrandrine
  参考文献：
  名称：

  Partial synthesis and biological evaluation of bisbenzylisoquinoline alkaloids derivatives: potential modulators of multidrug resistance in cancer

  摘要：

  A series of new bisbenzylisoquinoline alkaloids was partially synthesized from tetrandrine and fangchinoline and evaluated for their ability to reverse P-glycoprotein-mediated multidrug resistance (MDR) in cancer cells. All the test compounds increased the intracellular accumulation rate of rhodamine 123 in MDR cells (Bel7402 and HCT8), and most exhibited more potent MDR-reversing activity relative to the reference compound verapamil. Compounds 8, 10, 13, and 14 enhanced intracellular accumulation of doxorubicin in Bel7402 and HCT8 cells.

  DOI：

  10.1080/10286020.2012.680443

文献信息

• Partial synthesis and biological evaluation of bisbenzylisoquinoline alkaloids derivatives: potential modulators of multidrug resistance in cancer
  作者：Ping He、Hua Sun、Xi-Xian Jian、Qiao-Hong Chen、Dong-Lin Chen、Geng-Tao Liu、Feng-Peng Wang

  DOI：10.1080/10286020.2012.680443

  日期：2012.6

  A series of new bisbenzylisoquinoline alkaloids was partially synthesized from tetrandrine and fangchinoline and evaluated for their ability to reverse P-glycoprotein-mediated multidrug resistance (MDR) in cancer cells. All the test compounds increased the intracellular accumulation rate of rhodamine 123 in MDR cells (Bel7402 and HCT8), and most exhibited more potent MDR-reversing activity relative to the reference compound verapamil. Compounds 8, 10, 13, and 14 enhanced intracellular accumulation of doxorubicin in Bel7402 and HCT8 cells.